Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary
What is this summary about? This is a plain language summary of a published article in the journal CNS Drugs. Narcolepsy is a rare sleep condition. Most people with narcolepsy experience disrupted nighttime sleep and have poor quality of sleep. Sometimes these symptoms are not easily diagnosed as a...
Saved in:
Main Authors: | Thomas Roth (Author), Michael J Thorpy (Author), Clete A Kushida (Author), Matthew Horsnell (Author), Jennifer Gudeman (Author) |
---|---|
Format: | Book |
Published: |
Becaris Publishing Limited,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improvements in daytime sleepiness and disrupted nighttime sleep with once-nightly sodium oxybate in people with narcolepsy type 1 and type 2: a plain language summary
by: Yves Dauvilliers, et al.
Published: (2024) -
Population and Noncompartmental Pharmacokinetics of Sodium Oxybate Support Weight‐Based Dosing in Children and Adolescents With Narcolepsy With Cataplexy
by: Cuiping Chen, et al.
Published: (2020) -
Evaluation of pitolisant, sodium oxybate, solriamfetol, and modafinil for the management of narcolepsy: a retrospective analysis of the FAERS database
by: Xiaodan Zhou, et al.
Published: (2024) -
Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia
by: Leslie Citrome, et al.
Published: (2024) -
Evidence of Accidental Dosing Errors with Immediate-Release Sodium Oxybate: Data from the US Food and Drug Administration Adverse Event Reporting System
by: Jennifer Gudeman, et al.
Published: (2023)